EIF2A and pulmonary venoocclusive disease: These findings, combined with previous results (12), suggest that the depletion of PP1 and persistent eIF2α phosphorylation following MMC treatment mediate maladaptive ISR responses, triggering PVOD pathogenesis in both rats and humans (Figure 5D).